Loading...
3B BlackBio Dx Ltd
3BBLACKBIO.BO•BSE
Healthcare
Biotechnology
₹74.15(6.42%)
Indian Market opens in 34h 48m3B BlackBio Dx Ltd (3BBLACKBIO.BO) AI-Powered Stock Analysis
See how 3B BlackBio Dx Ltd scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer3B BlackBio Dx Ltd (3BBLACKBIO.BO) Stock Overall Grade
3B BlackBio Dx Ltd’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to 3B BlackBio Dx Ltd's overall stock rating.
Forecast
B+Score
70/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
50/100Key Ratios
C+Score
55/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
96/100Analyst Consensus
C+Score
50/1003B BlackBio Dx Ltd (3BBLACKBIO.BO) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 70/100 (B+), reflecting high confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (50/100, C+) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (96/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each 3B BlackBio Dx Ltd stock grade, including financials, comparisons, and forecasts.